Literature DB >> 26890332

DNA demethylation of the TIM-3 promoter is critical for its stable expression on T cells.

F-C Chou1, C-C Kuo1, H-Y Chen2, H-H Chen3, H-K Sytwu1,2.   

Abstract

The T-cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) is selectively expressed on terminally differentiated T helper 1 (Th1) cells and acts as a negative regulator that terminates Th1 responses. The dysregulation of TIM-3 expression on T cells is associated with several autoimmune phenotypes and with chronic viral infections; however, the mechanism of this regulation is unclear. In this study, we investigated the effect of DNA methylation on the expression of TIM-3. By analyzing the sequences of TIM-3 promoter regions in human and mouse, we identified a CpG island within the TIM-3 promoter and demonstrated that the promoter activity was controlled by DNA methylation. Furthermore, treatment with 5-aza-2'-deoxycytidine enhanced TIM-3 expression on mouse primary CD4(+) T cells under Th0-, Th1- or Th2-polarizing conditions. Finally, pyrosequencing analysis revealed that the methylation level of the TIM-3 promoter gradually decreased after each round of T-cell polarization, and this decrease was inversely correlated with TIM-3 expression. These data suggest that the DNA methylation of the TIM-3 promoter cooperates with lineage-specific transcription factors in the control of Th-cell development. In conclusion, DNA methylation-based regulation of TIM-3 may provide novel insights into understanding the dysregulation of TIM-3 expression under pathogenic conditions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26890332     DOI: 10.1038/gene.2016.6

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  52 in total

1.  Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

Authors:  Ben Youngblood; Kenneth J Oestreich; Sang-Jun Ha; Jaikumar Duraiswamy; Rama S Akondy; Erin E West; Zhengyu Wei; Peiyuan Lu; James W Austin; James L Riley; Jeremy M Boss; Rafi Ahmed
Journal:  Immunity       Date:  2011-09-23       Impact factor: 31.745

2.  T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development.

Authors:  Naganari Ohkura; Masahide Hamaguchi; Hiromasa Morikawa; Kyoko Sugimura; Atsushi Tanaka; Yoshinaga Ito; Motonao Osaki; Yoshiaki Tanaka; Riu Yamashita; Naoko Nakano; Jochen Huehn; Hans Joerg Fehling; Tim Sparwasser; Kenta Nakai; Shimon Sakaguchi
Journal:  Immunity       Date:  2012-11-01       Impact factor: 31.745

3.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

4.  Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway.

Authors:  Yumiko Kashio; Kazuhiro Nakamura; Mohammad J Abedin; Masako Seki; Nozomu Nishi; Naoko Yoshida; Takanori Nakamura; Mitsuomi Hirashima
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

5.  Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells.

Authors:  Karen W Makar; Mercedes Pérez-Melgosa; Maria Shnyreva; William M Weaver; David R Fitzpatrick; Christopher B Wilson
Journal:  Nat Immunol       Date:  2003-11-02       Impact factor: 25.606

6.  Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice.

Authors:  Feng-Cheng Chou; Shing-Jia Shieh; Huey-Kang Sytwu
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

7.  Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells.

Authors:  Lucy Golden-Mason; Brent E Palmer; Nasim Kassam; Lisa Townshend-Bulson; Stephen Livingston; Brian J McMahon; Nicole Castelblanco; Vijay Kuchroo; David R Gretch; Hugo R Rosen
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

8.  Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation.

Authors:  Haruna Niwa; Takahiro Satoh; Yuki Matsushima; Kazuki Hosoya; Kazumi Saeki; Toshiro Niki; Mitsuomi Hirashima; Hiroo Yokozeki
Journal:  Clin Immunol       Date:  2009-05-23       Impact factor: 3.969

9.  Dysregulated T cell expression of TIM3 in multiple sclerosis.

Authors:  Ken Koguchi; David E Anderson; Li Yang; Kevin C O'Connor; Vijay K Kuchroo; David A Hafler
Journal:  J Exp Med       Date:  2006-06-05       Impact factor: 14.307

10.  Regulation of DNA methylation dictates Cd4 expression during the development of helper and cytotoxic T cell lineages.

Authors:  MacLean Sellars; Jun R Huh; Kenneth Day; Priya D Issuree; Carolina Galan; Stephane Gobeil; Devin Absher; Michael R Green; Dan R Littman
Journal:  Nat Immunol       Date:  2015-06-01       Impact factor: 25.606

View more
  5 in total

1.  Acute stimulation generates Tim-3-expressing T helper type 1 CD4 T cells that persist in vivo and show enhanced effector function.

Authors:  Jacob V Gorman; John D Colgan
Journal:  Immunology       Date:  2018-02-08       Impact factor: 7.397

2.  Downregulated Tim-3 expression is responsible for the incidence and development of colorectal cancer.

Authors:  Ping Zhang; Yan Wang; Xue-Rong Liu; Shi-Ru Hong; Jian Yao
Journal:  Oncol Lett       Date:  2018-05-11       Impact factor: 2.967

Review 3.  Cell death pathologies: targeting death pathways and the immune system for cancer therapy.

Authors:  Francesca Pentimalli; Sandro Grelli; Nicola Di Daniele; Gerry Melino; Ivano Amelio
Journal:  Genes Immun       Date:  2018-12-19       Impact factor: 2.676

4.  Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma.

Authors:  Tobias A W Holderried; Luka de Vos; Emma Grace Bawden; Timo J Vogt; Joern Dietrich; Romina Zarbl; Friedrich Bootz; Glen Kristiansen; Peter Brossart; Jennifer Landsberg; Dimo Dietrich
Journal:  Clin Epigenetics       Date:  2019-11-20       Impact factor: 6.551

5.  Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer.

Authors:  Li Zhang; Sijuan Tian; Meili Pei; Minyi Zhao; Li Wang; Yifan Jiang; Ting Yang; Juan Zhao; Lihua Song; Xiaofeng Yang
Journal:  Oncol Rep       Date:  2019-10-24       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.